Cutler Group LP Uro Gen Pharma Ltd. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 18, 2024	SELL	$10.87 - $15.93 $2,174 - $3,186	-200 Reduced 11.11%	1,600 $5,000
Q3 2023 Nov 07, 2023	BUY	$8.84 - $22.64 $15,912 - $40,752	1,800 New	1,800 $1,000
Q1 2023 May 01, 2023	BUY	$7.99 - $11.02 $3,196 - $4,408	400 Added 400.0%	500 $0
Q4 2022 Feb 07, 2023	BUY	$7.55 - $11.9 $755 - $1,190	100 New	100 $0
Q4 2020 Jan 21, 2021	SELL	$17.54 - $25.43 $3,508 - $5,086	-200 Closed	0 $0

Q3 2020 Oct 27, 2020	SELL	$18.81 - $26.42 $62,072 - $87,186	-3,300 Reduced 94.29%	200 $0
Q2 2020 Jul 22, 2020	BUY	$16.5 - $29.7 $57,750 - $103,950	3,500 New	3,500 $12,000

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $361M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.